Biomedical Engineering Reference
In-Depth Information
114. Paschalis, E.P., Burr, D.B., Mendelsohn, R., Hock, J.M., Boskey, A.L.: Bone mineral and
collagen quality in humeri of ovariectomized cynomolgus monkeys given rhPTH(1-34) for
18 months. J. Bone Miner. Res 18, 769-775 (2003)
115. Dobnig, H., Stepan, J.J., Burr, D.B., Li, J., Michalska, D., Sipos, A., Petto, H., Fahrleitner-
Pammer, A., Pavo, I.: Teriparatide reduces bone microdamage accumulation in
postmenopausal women previously treated with alendronate. J. Bone Miner. Res. 24,
1998-2006 (2009)
116. Ejersted, C., Andreassen, T.T., Hauge, E.M., Melsen, F., Oxlund, H.: Parathyroid
hormone(1-34) increases vertebral bone mass, compressive strength, and quality in old
rats. Bone 17, 507-511 (1995)
117. Boonen, S., Marin, F., Obermayer-Pietsch, B., Simoes, M.E., Barker, C., Glass, E.V., Hadji, P.,
Lyritis, G., Oertel, H., Nickelsen, T., McCloskey, E.V.: Effects of previous antiresorptive
therapy on the bone mineral density response to two years of teriparatide treatment in
postmenopausal women with osteoporosis. J. Clin. Endocrinol. Metab. 93, 852-860 (2008)
118. Miller, P.D., Delmas, P.D., Lindsay, R., Watts, N.B., Luckey, M., Adachi, J., Saag, K.,
Greenspan, S.L., Seeman, E., Boonen, S., Meeves, S., Lang, T.F., Bilezikian, J.P.: Early
responsiveness of women with osteoporosis to teriparatide after therapy with alendronate or
risedronate. J. Clin. Endocrinol. Metab. 93, 3785-3793 (2008)
119. Stepan, J.J., Burr, D.B., Li, J., Ma, Y.L., Petto, H., Sipos, A., Dobnig, H., Fahrleitner-
Pammer, A., Michalska,
D., Pavo, I.: Histomorphometric
changes by teriparatide
in
alendronate-pretreated women with osteoporosis. Osteoporos. Int. 5, 5 (2010)
120. Black, D.M., Greenspan, S.L., Ensrud, K.E., Palermo, L., McGowan, J.A., Lang, T.F.,
Garnero, P., Bouxsein, M.L., Bilezikian, J.P., Rosen, C.J.: The effects of parathyroid
hormone and alendronate alone or in combination in postmenopausal osteoporosis. N. Engl.
J. Med. 349, 1207-1215 (2003)
121. Greenspan, S.L., Emkey, R.D., Bone, H.G., Weiss, S.R., Bell, N.H., Downs, R.W., McKeever, C.,
Miller, S.S., Davidson, M., Bolognese, M.A., Mulloy, A.L., Heyden, N., Wu, M., Kaur, A.,
Lombardi, A.: Significant differential effects of alendronate, estrogen, or combination therapy on
the rate of bone loss after discontinuation of treatment of postmenopausal osteoporosis. A
randomized, double-blind, placebo-controlled trial. Ann. Intern. Med. 137, 875-883 (2002)
122. Cosman, F., Wermers, R.A., Recknor, C., Mauck, K.F., Xie, L., Glass, E.V., Krege, J.H.:
Effects of teriparatide in postmenopausal women with osteoporosis on prior alendronate or
raloxifene: differences between stopping and continuing the antiresorptive agent. J. Clin.
Endocrinol. Metab. 94, 3772-3780 (2009)
123. Vestergaard, P., Jorgensen, N.R., Mosekilde, L., Schwarz, P.: Effects of parathyroid
hormone alone or in combination with antiresorptive therapy on bone mineral density and
fracture risk-a meta-analysis. Osteoporos. Int. 18, 45-57 (2007)
124. Chevalier, Y., Quek, E., Borah, B., Gross, G., Stewart, J., Lang, T., Zysset, P.:
Biomechanical effects of teriparatide in women with osteoporosis treated previously with
alendronate and risedronate: results from quantitative computed tomography-based finite
element analysis of the vertebral body. Bone 46, 41-48 (2010)
125. Ma, Y.L., Bryant, H.U., Zeng, Q., Schmidt, A., Hoover, J., Cole, H.W., Yao, W., Jee, W.S.,
Sato, M.: New bone formation with teriparatide [human parathyroid hormone-(1-34)] is not
retarded
by
long-term
pretreatment
with
alendronate,
estrogen,
or
raloxifene
in
ovariectomized rats. Endocrinology 144, 2008-2015 (2003)
126. Samadfam, R., Xia, Q., Goltzman, D.: Pretreatment with anticatabolic agents blunts but
does
not
eliminate
the
skeletal
anabolic
response
to
parathyroid
hormone
in
oophorectomized mice. Endocrinology 148, 2778-2787 (2007)
127. Yao, W., Su, M., Zhang, Q., Tian, X., Setterberg, R.B., Blanton, C., Lundy, M.W., Phipps, R.,
Jee, W.S.: Risedronate did not block the maximal anabolic effect of PTH in aged rats. Bone 41,
813-819 (2007)
128. Minne, H., Audran, M., Simoes, M.E., Obermayer-Pietsch, B., Sigurethsson, G., Marin, F.,
Dalsky, G.P., Group, T.N.: Bone density after teriparatide in patients with or without prior
Search WWH ::
Custom Search